Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells

Applied Biochemistry and Biotechnology

Volumn 172, Issue 2, 2014, Pages 784-791

  Zhao, Ji Ling ^a   Zhao, Jing ^a   Jiao, Hong Jun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Chemotherapy; Hepatocellular carcinoma; p16; Quercetin; Synergism

Indexed keywords

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; G1 PHASE CELL CYCLE CHECKPOINTS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; QUERCETIN;

EID: 84894460009     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-013-0561-z     Document Type: Article

References (31)

1. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. (2005). CA: A Cancer Journal for Clinicians, 55, 74-108.
2. Farazi, P. A.; DePinho, R. A. (2006). Nature Reviews Cancer, 6, 674-687.
3. Sadowitz, P. D.; Hubbard, B. A.; Dabrowiak, J. C.; Goodisman, J.; Tacka, K. A.; Aktas, M. K.; et al. (2002). Drug Metabolism and Disposition, 30, 183-190.
4. Carr, B. I.; Bron, K.; Swanson, D. P. (2011). Journal of Clinical Gastroenterology, 45, e87-e91.
5. Yamanaka, K.; Hatano, E.; Narita, M.; Taura, K.; Yasuchika, K.; Nitta, T.; et al. (2011). Hepatology Research, 41, 303-309.
6. Yang, J. X.; Luo, Y.; Qiu, H. M.; Tang, W. X. (2009). Saudi Medical Journal, 30, 35-40.
7. Dong, Z.; Atherton, S. S. (2007). Kidney International, 72, 5-7.
8. Gibellini, L.; Pinti, M.; Nasi, M.; Montagna, J. P.; De Biasi, S.; Roat, E.; et al. (2011). Evidence-based Complementary and Alternative Medicine, 2011, 591356.
9. Chuang-Xin, L.; Wen-Yu, W.; Yao, C.; Xiao-Yan, L.; Yun, Z. (2012). Oncology Letters, 4, 775-778.
10. Angst, E.; Park, J. L.; Moro, A.; Lu, Q. Y.; Lu, X.; Li, G.; et al. (2013). Pancreas, 42, 223-229.
11. Zhang, H.; Zhang, M.; Yu, L.; Zhao, Y.; He, N.; Yang, X. (2012). Food and Chemical Toxicology, 50, 1589-1599.
12. Mu, C.; Jia, P.; Yan, Z.; Liu, X.; Li, X.; Liu, H. (2007). Methods and Findings in Experimental and Clinical Pharmacology, 29, 179-183.
13. Duo, J.; Ying, G. G.; Wang, G. W.; Zhang, L. (2012). Molecular Medicine Reports, 5, 1453-1456.
14. Tan, J.; Wang, B.; Zhu, L. (2009). Chemistry and Biodiversity, 6, 1101-1110.
15. Staedler, D.; Idrizi, E.; Kenzaoui, B. H.; Juillerat-Jeanneret, L. (2011). Cancer Chemotherapy and Pharmacology, 68, 1161-1172.
16. Qin, L. F.; Ng, I. O. (2002). Cancer Letters, 175, 27-38.
17. Granado-Serrano, A. B.; Martín, M. A.; Bravo, L.; Goya, L.; Ramos, S. (2010). Nutrition and Cancer, 62, 390-401.
18. Suh, D. K.; Lee, E. J.; Kim, H. C.; Kim, J. H. (2010). Arch Pharmacal Research, 33, 781-785.
19. Choi, J. A.; Kim, J. Y.; Lee, J. Y.; Kang, C. M.; Kwon, H. J.; Yoo, Y. D.; et al. (2001). International Journal of Oncology, 19, 837-844.
20. Tanigawa, S.; Fujii, M.; Hou, D. X. (2008). Bioscience, Biotechnology, and Biochemistry, 72, 797-804.
21. Granado-Serrano, A. B.; Martín, M. A.; Bravo, L.; Goya, L.; Ramos, S. (2006). Journal of Nutrition, 136, 2715-2721.
22. Serrano, M.; Hannon, G. J.; Beach, D. (1993). Nature, 366, 704-707.
23. Park, S. H.; Lim, J. S.; Jang, K. L. (2011). Cancer Letters, 310, 232-239.
24. Han, J.; Tsukada, Y.; Hara, E.; Kitamura, N.; Tanaka, T. (2005). Journal of Biological Chemistry, 280, 31548-31556.
25. Liu, L. H.; Xiao, W. H.; Liu, W. W. (2001). World Journal of Gastroenterology, 7, 131-135.
26. Tan, S.; Wang, C.; Lu, C.; Zhao, B.; Cui, Y.; Shi, X.; et al. (2009). Chemotherapy, 55, 6-10.
27. Hu, H.; Li, Z.; Chen, J.; Wang, D.; Ma, J.; Wang, W.; et al. (2011). Gut, 60, 710-721.
28. Lu, Y.; Zhang, X.; Zhang, J. (2012). Journal of Cancer, 3, 333-344.
29. Daker, M.; Ahmad, M.; Khoo, A. S. (2012). Cancer Cell International, 12, 34.
30. Demiroglu-Zergeroglu, A.; Basara-Cigerim, B.; Kilic, E.; Yanikkaya-Demirel, G. (2010). Journal of Biomedicine and Biotechnology, 2010, 851589.
31. Sharma, H.; Sen, S.; Singh, N. (2005). Cancer Biology and Therapy, 4, 949-955.